175 related articles for article (PubMed ID: 15168802)
21. Kinetics of chemokines in acute myocardial infarction.
Kobusiak-Prokopowicz M; Orzeszko J; Mazur G; Mysiak A; Orda A; Mazurek W
Kardiol Pol; 2005 Apr; 62(4):301-14; discussion 315-6. PubMed ID: 15928736
[TBL] [Abstract][Full Text] [Related]
22. Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses.
Chou R; Fu R; Huffman LH; Korthuis PT
Lancet; 2006 Oct; 368(9546):1503-15. PubMed ID: 17071284
[TBL] [Abstract][Full Text] [Related]
23. Absence of favourable changes in circulating levels of interleukin-16 or beta-chemokine concentration following structured intermittent interruption treatment of chronic human immunodeficiency virus infection.
Montes de Oca Arjona M; Pérez Cano R; Orozco MJ; Martín Aspas A; Guerrero F; Fernández Gutiérrez Del Alamo C; Girón-González JA
Clin Microbiol Infect; 2005 Jan; 11(1):57-62. PubMed ID: 15649305
[TBL] [Abstract][Full Text] [Related]
24. A rapid chemokine response of macrophage inflammatory protein (MIP)-1α, MIP-1β and the regulated on activation, normal T expressed and secreted chemokine is associated with a sustained virological response in the treatment of chronic hepatitis C.
Florholmen J; Kristiansen MG; Steigen SE; Sørbye SW; Paulssen EJ; Kvamme JM; Konopski Z; Gutteberg T; Goll R
Clin Microbiol Infect; 2011 Feb; 17(2):204-9. PubMed ID: 20219081
[TBL] [Abstract][Full Text] [Related]
25. A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults.
Lalezari JP; DeJesus E; Northfelt DW; Richmond G; Wolfe P; Haubrich R; Henry D; Powderly W; Becker S; Thompson M; Valentine F; Wright D; Carlson M; Riddler S; Haas FF; DeMasi R; Sista PR; Salgo M; Delehanty J
Antivir Ther; 2003 Aug; 8(4):279-87. PubMed ID: 14518696
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases.
Silva TA; Garlet GP; Lara VS; Martins W; Silva JS; Cunha FQ
Oral Microbiol Immunol; 2005 Oct; 20(5):310-6. PubMed ID: 16101967
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor-alpha increases chemokine gene expression and production in synovial fibroblasts from human temporomandibular joint.
Ogura N; Tobe M; Sakamaki H; Nagura H; Abiko Y; Kondoh T
J Oral Pathol Med; 2005 Jul; 34(6):357-63. PubMed ID: 15946184
[TBL] [Abstract][Full Text] [Related]
28. Intermittent episodes of detectable HIV viremia in patients receiving nonnucleoside reverse-transcriptase inhibitor-based or protease inhibitor-based highly active antiretroviral therapy regimens are equivalent in incidence and prognosis.
Sungkanuparph S; Overton ET; Seyfried W; Groger RK; Fraser VJ; Powderly WG
Clin Infect Dis; 2005 Nov; 41(9):1326-32. PubMed ID: 16206110
[TBL] [Abstract][Full Text] [Related]
29. Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.
Kuntzen T; Tural C; Li B; Feldmann G; Kupfer B; Nischalke HD; Clotet B; Sauerbruch T; Rockstroh JK; Spengler U
AIDS; 2008 Jan; 22(2):203-10. PubMed ID: 18097222
[TBL] [Abstract][Full Text] [Related]
30. Chemokine mRNA expression in the cauda equina of Lewis rats with experimental allergic neuritis.
Fujioka T; Purev E; Rostami A
J Neuroimmunol; 1999 Jun; 97(1-2):51-9. PubMed ID: 10408979
[TBL] [Abstract][Full Text] [Related]
31. A once-daily HAART regimen containing indinavir + ritonavir plus one or two nucleoside reverse transcriptase inhibitors (PIPO study).
Burger DM; Aarnoutse RE; Dieleman JP; Gyssens IC; Nouwen J; de Marie S; Koopmans PP; Stek M; van der Ende ME
Antivir Ther; 2003 Oct; 8(5):455-61. PubMed ID: 14640393
[TBL] [Abstract][Full Text] [Related]
32. Two-year outcomes of children on non-nucleoside reverse transcriptase inhibitor and protease inhibitor regimens in a South African pediatric antiretroviral program.
Jaspan HB; Berrisford AE; Boulle AM
Pediatr Infect Dis J; 2008 Nov; 27(11):993-8. PubMed ID: 18818556
[TBL] [Abstract][Full Text] [Related]
33. Blockade of neurokinin-1 receptor attenuates CC and CXC chemokine production in experimental acute pancreatitis and associated lung injury.
Sun J; Bhatia M
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G143-53. PubMed ID: 16873893
[TBL] [Abstract][Full Text] [Related]
34. Intracellular and plasma efavirenz concentrations in HIV-infected patients switching from successful protease inhibitor-based highly active antiretroviral therapy (HAART) to efavirenz-based HAART (SUSTIPHAR Study).
Djabarouti S; Breilh D; Pellegrin I; Lavit M; Camou F; Caubet O; Fleury H; Saux MC; Pellegrin JL
J Antimicrob Chemother; 2006 Nov; 58(5):1090-3. PubMed ID: 16921181
[TBL] [Abstract][Full Text] [Related]
35. Increased resilience to the development of drug resistance with modern boosted protease inhibitor-based highly active antiretroviral therapy.
Lima VD; Gill VS; Yip B; Hogg RS; Montaner JS; Harrigan PR
J Infect Dis; 2008 Jul; 198(1):51-8. PubMed ID: 18498238
[TBL] [Abstract][Full Text] [Related]
36. Transient and sequential expression of chemokine mRNA in glomeruli in puromycin aminonucleoside nephrosis.
Ou ZL; Natori Y; Natori Y
Nephron; 2000 Jul; 85(3):254-7. PubMed ID: 10867541
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line.
Biswas P; Delfanti F; Bernasconi S; Mengozzi M; Cota M; Polentarutti N; Mantovani A; Lazzarin A; Sozzani S; Poli G
Blood; 1998 Jan; 91(1):258-65. PubMed ID: 9414293
[TBL] [Abstract][Full Text] [Related]
38. Sequential expression of chemokines in experimental autoimmune neuritis.
Kieseier BC; Krivacic K; Jung S; Pischel H; Toyka KV; Ransohoff RM; Hartung HP
J Neuroimmunol; 2000 Oct; 110(1-2):121-9. PubMed ID: 11024541
[TBL] [Abstract][Full Text] [Related]
39. Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis.
Sadek MI; Sada E; Toossi Z; Schwander SK; Rich EA
Am J Respir Cell Mol Biol; 1998 Sep; 19(3):513-21. PubMed ID: 9730880
[TBL] [Abstract][Full Text] [Related]
40. Low density lipoprotein apolipoprotein B metabolism in treatment-naive HIV patients and patients on antiretroviral therapy.
Umpleby AM; Das S; Stolinski M; Shojaee-Moradie F; Jackson NC; Jefferson W; Crabtree N; Nightingale P; Shahmanesh M
Antivir Ther; 2005; 10(5):663-70. PubMed ID: 16152760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
